Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
(2R,6R)-HNK in Acute Pain in Healthy Volunteers
NCT07504601Phase 2Not yet recruiting
- Sponsor
- National Center for Complementary and Integrative Health
- Start
- Nov 2026
- Primary completion
- Dec 2030
- Countries
- 1
01
Overview
A Phase 2 trial of (2R,6R)-hydroxynorketamine in acute pain, sponsored by National Center for Complementary and Integrative Health. Planned start Nov 2026; status: not yet recruiting.
02
Drugs
(2R,6R)-hydroxynorketamine
03
Conditions
acute pain
Beyond the preview
Go deeper on NCT07504601.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07504601.